| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ... Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013 | 608 | 2013 |
| Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab R Stasi, N Cooper, G Del Poeta, E Stipa, M Laura Evangelista, ... Blood, The Journal of the American Society of Hematology 112 (4), 1147-1150, 2008 | 492 | 2008 |
| Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) Presented in part at the 42nd annual meeting of the American … G Del Poeta, A Venditti, MI Del Principe, L Maurillo, F Buccisano, ... Blood, The Journal of the American Society of Hematology 101 (6), 2125-2131, 2003 | 458 | 2003 |
| Clinical significance of CD38 expression in chronic lymphocytic leukemia G Del Poeta, L Maurillo, A Venditti, F Buccisano, AM Epiceno, G Capelli, ... Blood, The Journal of the American Society of Hematology 98 (9), 2633-2639, 2001 | 397 | 2001 |
| Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura R Stasi, G Del Poeta, E Stipa, ML Evangelista, MM Trawinska, N Cooper, ... Blood, The Journal of the American Society of Hematology 110 (8), 2924-2930, 2007 | 395 | 2007 |
| Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society … A Venditti, F Buccisano, G Del Poeta, L Maurillo, A Tamburini, C Cox, ... Blood, The Journal of the American Society of Hematology 96 (12), 3948-3952, 2000 | 346 | 2000 |
| Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia F Buccisano, L Maurillo, MI Del Principe, G Del Poeta, G Sconocchia, ... Blood, The Journal of the American Society of Hematology 119 (2), 332-341, 2012 | 338 | 2012 |
| Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia V Gattei, P Bulian, MI Del Principe, A Zucchetto, L Maurillo, F Buccisano, ... Blood, The Journal of the American Society of Hematology 111 (2), 865-873, 2008 | 317 | 2008 |
| Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab R Stasi, E Stipa, G Del Poeta, S Amadori, AC Newland, D Provan Rheumatology 45 (11), 1432-1436, 2006 | 302 | 2006 |
| Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ... Blood, The Journal of the American Society of Hematology 126 (16), 1921-1924, 2015 | 266 | 2015 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 264 | 2020 |
| Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ... Blood 108 (3), 853-861, 2006 | 241 | 2006 |
| CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia Pietro Bulian, Tait D. Shanafelt, Chris Fegan, Antonella Zucchetto, Lilla ... JOURNAL OF CLINICAL ONCOLOGY 32 (9), 897-904, 2014 | 231 | 2014 |
| Toward optimization of postremission therapy for residual disease–positive patients with acute myeloid leukemia L Maurillo, F Buccisano, MI Del Principe, G Del Poeta, A Spagnoli, ... Journal of Clinical Oncology 26 (30), 4944-4951, 2008 | 195 | 2008 |
| CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival A Zucchetto, D Benedetti, C Tripodo, R Bomben, M Dal Bo, D Marconi, ... Cancer research 69 (9), 4001-4009, 2009 | 183 | 2009 |
| Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult … F Buccisano, L Maurillo, A Spagnoli, MI Del Principe, D Fraboni, ... Blood, The Journal of the American Society of Hematology 116 (13), 2295-2303, 2010 | 177 | 2010 |
| Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, ... | 173 | 1996 |
| The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia F Buccisano, L Maurillo, V Gattei, G Del Poeta, MI Del Principe, MC Cox, ... Leukemia 20 (10), 1783-1789, 2006 | 166 | 2006 |
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia D Rossi, V Spina, R Bomben, S Rasi, M Dal-Bo, A Bruscaggin, FM Rossi, ... Blood, The Journal of the American Society of Hematology 121 (24), 4902-4905, 2013 | 164 | 2013 |
| Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study R Bomben, M Dal Bo, D Capello, F Forconi, R Maffei, L Laurenti, D Rossi, ... British journal of haematology 144 (4), 492-506, 2009 | 152 | 2009 |
